跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ulcerative colitis therapy
首页
药物
ulcerative colitis therapy
ulcerative colitis therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pyrrolo[2,3-d]pyrimidine compounds
US 6956041 B2
申请人: PFIZER
优先权: 2000
US
13 件公开
US 7569569 B2
申请人: PFIZER
优先权: 2003
US
2 件公开
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
US 7361733 B2
申请人: CORIXA CORP
优先权: 2003
US
12 件公开
COMBINATION THERAPY OF C-C CHEMOKINE RECEPTOR-9 (CCR9) INHIBITORS AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
EP 4268820 C0
申请人: CHEMOCENTRYX INC
优先权: 2014
CN
EP
US
WO
11 件公开
Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
US 8143404 B2
申请人: TAKAOKA YOSHIKAZU
优先权: 2004
CN
EP
US
8 件公开
SAFE AND EFFECTIVE METHOD OF TREATING ULCERATIVE COLITIS WITH ANTI-IL12/IL23 ANTIBODY
EP 3883606 A4
申请人: JANSSEN BIOTECH INC
优先权: 2018
CN
EP
US
WO
7 件公开
EP 4045085 A4
申请人: JANSSEN BIOTECH INC
优先权: 2019
CN
EP
US
WO
6 件公开
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING CCR9 INHIBITOR AND ANTI-IL-23 BLOCKING ANTIBODIES
EP 4125849 A4
申请人: CHEMOCENTRYX INC
优先权: 2020
CN
EP
US
WO
6 件公开
Pyrrolo [2,3-D] pyrimidine compounds
US 6890929 B2
申请人: PFIZER
优先权: 2001
US
6 件公开
N-ACYL-{4-[(4-ARYL-PHENYL)SULFONYLMETHYL]PIPERIDINE} COMPOUNDS AND THEIR THERAPEUTIC USE
EP 3956030 C0
申请人: ISTESSO THERAPEUTICS LTD
优先权: 2019
CN
EP
US
WO
5 件公开
Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist
US 7939076 B2
申请人: MEDAREX INC
优先权: 2003
CN
US
5 件公开
Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
US 7122336 B2
申请人: UNIV NEW JERSEY MED
优先权: 2001
US
5 件公开
第 1 / 8 页
上一页
下一页
药物
反馈